These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38783705)

  • 1. Mutational signatures of colorectal cancers according to distinct computational workflows.
    Battuello P; Corti G; Bartolini A; Lorenzato A; Sogari A; Russo M; Di Nicolantonio F; Bardelli A; Crisafulli G
    Brief Bioinform; 2024 May; 25(4):. PubMed ID: 38783705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of mutational signatures with yet another package for signature analysis.
    Hübschmann D; Jopp-Saile L; Andresen C; Krämer S; Gu Z; Heilig CE; Kreutzfeldt S; Teleanu V; Fröhling S; Eils R; Schlesner M
    Genes Chromosomes Cancer; 2021 May; 60(5):314-331. PubMed ID: 33222322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients.
    Johansen AFB; Kassentoft CG; Knudsen M; Laursen MB; Madsen AH; Iversen LH; Sunesen KG; Rasmussen MH; Andersen CL
    BMC Cancer; 2019 Oct; 19(1):971. PubMed ID: 31638937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two main mutational processes operate in the absence of DNA mismatch repair.
    Németh E; Lovrics A; Gervai JZ; Seki M; Rospo G; Bardelli A; Szüts D
    DNA Repair (Amst); 2020 May; 89():102827. PubMed ID: 32126497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers.
    Georgeson P; Pope BJ; Rosty C; Clendenning M; Mahmood K; Joo JE; Walker R; Hutchinson RA; Preston S; Como J; Joseland S; Win AK; Macrae FA; Hopper JL; Mouradov D; Gibbs P; Sieber OM; O'Sullivan DE; Brenner DR; Gallinger S; Jenkins MA; Winship IM; Buchanan DD
    Gut; 2021 Nov; 70(11):2138-2149. PubMed ID: 33414168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
    PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome.
    Georgeson P; Walsh MD; Clendenning M; Daneshvar S; Pope BJ; Mahmood K; Joo JE; Jayasekara H; Jenkins MA; Winship IM; Buchanan DD
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00781. PubMed ID: 31162827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted exome sequencing reveals distinct pathogenic variants in Iranians with colorectal cancer.
    Ashktorab H; Mokarram P; Azimi H; Olumi H; Varma S; Nickerson ML; Brim H
    Oncotarget; 2017 Jan; 8(5):7852-7866. PubMed ID: 28002797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ScalpelSig Designs Targeted Genomic Panels from Data to Detect Activity of Mutational Signatures.
    Franzese N; Fan J; Sharan R; Leiserson MDM
    J Comput Biol; 2022 Jan; 29(1):56-73. PubMed ID: 34986026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CloneSig can jointly infer intra-tumor heterogeneity and mutational signature activity in bulk tumor sequencing data.
    Abécassis J; Reyal F; Vert JP
    Nat Commun; 2021 Sep; 12(1):5352. PubMed ID: 34504064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Positively and Negatively Selected Driver Gene Mutations Associated With Colorectal Cancer With Microsatellite Instability.
    Jonchere V; Marisa L; Greene M; Virouleau A; Buhard O; Bertrand R; Svrcek M; Cervera P; Goloudina A; Guillerm E; Coulet F; Landman S; Ratovomanana T; Job S; Ayadi M; Elarouci N; Armenoult L; Merabtene F; Dumont S; Parc Y; Lefèvre JH; André T; Fléjou JF; Guilloux A; Collura A; de Reyniès A; Duval A
    Cell Mol Gastroenterol Hepatol; 2018; 6(3):277-300. PubMed ID: 30116770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples.
    Díaz-Gay M; Vila-Casadesús M; Franch-Expósito S; Hernández-Illán E; Lozano JJ; Castellví-Bel S
    BMC Bioinformatics; 2018 Jun; 19(1):224. PubMed ID: 29898651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatic Methods to Identify Mutational Signatures in Cancer.
    Islam SMA; Alexandrov LB
    Methods Mol Biol; 2021; 2185():447-473. PubMed ID: 33165866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic mutational signatures in polyposis and colorectal cancer.
    Grolleman JE; Díaz-Gay M; Franch-Expósito S; Castellví-Bel S; de Voer RM
    Mol Aspects Med; 2019 Oct; 69():62-72. PubMed ID: 31108140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy.
    Hatakeyama K; Nagashima T; Ohshima K; Ohnami S; Ohnami S; Shimoda Y; Serizawa M; Maruyama K; Naruoka A; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
    Cancer Sci; 2019 Aug; 110(8):2620-2628. PubMed ID: 31152682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational signatures reveal ternary relationships between homologous recombination repair, APOBEC, and mismatch repair in gynecological cancers.
    Farmanbar A; Firouzi S; Kneller R; Khiabanian H
    J Transl Med; 2022 Feb; 20(1):65. PubMed ID: 35109853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational tools to detect signatures of mutational processes in DNA from tumours: A review and empirical comparison of performance.
    Omichessan H; Severi G; Perduca V
    PLoS One; 2019; 14(9):e0221235. PubMed ID: 31513583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliable Analysis of Clinical Tumor-Only Whole-Exome Sequencing Data.
    Oh S; Geistlinger L; Ramos M; Morgan M; Waldron L; Riester M
    JCO Clin Cancer Inform; 2020 Apr; 4():321-335. PubMed ID: 32282230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependencies.
    Degasperi A; Amarante TD; Czarnecki J; Shooter S; Zou X; Glodzik D; Morganella S; Nanda AS; Badja C; Koh G; Momen SE; Georgakopoulos-Soares I; Dias JML; Young J; Memari Y; Davies H; Nik-Zainal S
    Nat Cancer; 2020 Feb; 1(2):249-263. PubMed ID: 32118208
    [No Abstract]   [Full Text] [Related]  

  • 20. Analysis of mutational signatures in C. elegans: Implications for cancer genome analysis.
    Meier B; Volkova NV; Gerstung M; Gartner A
    DNA Repair (Amst); 2020 Nov; 95():102957. PubMed ID: 32980770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.